{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:45:00Z","timestamp":1790703900376,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China \uff082022\uff09","award":["82274539"],"award-info":[{"award-number":["82274539"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ligamentum flavum (LF) hypertrophy is the main cause of lumbar spinal canal stenosis (LSCS). Previous studies have shown that LF hypertrophy tissue exhibits abnormal lipid accumulation, but the regulatory mechanism remains unclear. The objective of this study was to explore the function and potential mechanism of ACSM5 in LF lipid accumulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To assess the ACSM5 expression levels, lipid accumulation and triglyceride (TG) level in LF hypertrophy and normal tissue, we utilized RT-qPCR, western blot, oil red O staining, and TG assay kit. The pearson correlation coefficient assay was used to analyze the correlation between ACSM5 levels and lipid accumulation or TG levels in LF hypertrophy tissue. The role of ACSM5 in free fatty acids (FFA)-induced lipid accumulation in LF cells was assessed in vitro, and the role of ACSM5 in LF hypertrophy in mice was verified in vivo. To investigate the underlying mechanisms of ACSM5 regulating lipid accumulation in LF, we conducted the mRNA sequencing, bioinformatics analysis, and rescue experiments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In this study, we found that ACSM5, which was significantly down-regulated in LF tissues, correlated with lipid accumulation. In vitro cell experiments demonstrated that overexpression of ACSM5 significantly inhibited FFA-induced lipid accumulation and fibrosis in LF cells. In vivo animal experiments further confirmed that overexpression of ACSM5 inhibited LF thickening, lipid accumulation, and fibrosis. Mechanistically, ACSM5 inhibited lipid accumulation of LF cells by inhibiting FABP4-mediated PPAR\u03b3 signaling pathway, thereby improving hypertrophy and fibrosis of LF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>our findings elucidated the important role of ACSM5 in the regulation of LF lipid accumulation and provide insight into potential therapeutic interventions for the treatment of LF hypertrophy. This study further suggested that therapeutic strategies targeting lipid deposition may be an effective potential approach to treat LF hypertrophy-induced LSCS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13062-023-00436-z","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T22:01:56Z","timestamp":1699912916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["ACSM5 inhibits ligamentum flavum hypertrophy by regulating lipid accumulation mediated by FABP4\/PPAR signaling pathway"],"prefix":"10.1186","volume":"18","author":[{"given":"Yanlin","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songjia","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,14]]},"reference":[{"issue":"9","key":"436_CR1","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1007\/s00586-020-06524-2","volume":"29","author":"MKL Lai","year":"2020","unstructured":"Lai MKL, Cheung PWH, Cheung JPY. A systematic review of developmental lumbar spinal stenosis. Eur Spine J. 2020;29(9):2173\u201387.","journal-title":"Eur Spine J"},{"issue":"4","key":"436_CR2","doi-asserted-by":"publisher","first-page":"e1210","DOI":"10.1002\/jsp2.1210","volume":"5","author":"Y Yabe","year":"2022","unstructured":"Yabe Y, et al. Comparative proteome analysis of the ligamentum flavum of patients with lumbar spinal canal stenosis. JOR Spine. 2022;5(4):e1210.","journal-title":"JOR Spine"},{"issue":"4","key":"436_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.spinee.2021.11.003","volume":"22","author":"F Hayashi","year":"2022","unstructured":"Hayashi F, et al. Myofibroblasts are increased in the dorsal layer of the hypertrophic ligamentum flavum in lumbar spinal canal stenosis. Spine J. 2022;22(4):697\u2013704.","journal-title":"Spine J"},{"key":"436_CR4","doi-asserted-by":"publisher","first-page":"101540","DOI":"10.1016\/j.molmet.2022.101540","volume":"63","author":"K Xu","year":"2022","unstructured":"Xu K, et al. A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression. Mol Metab. 2022;63:101540.","journal-title":"Mol Metab"},{"issue":"18","key":"436_CR5","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1042\/CS20220572","volume":"136","author":"OO Badmus","year":"2022","unstructured":"Badmus OO, et al. Molecular mechanisms of metabolic associated fatty Liver Disease (MAFLD): functional analysis of lipid metabolism pathways. Clin Sci (Lond). 2022;136(18):1347\u201366.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"436_CR6","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/s41467-021-21931-9","volume":"12","author":"GG Schiattarella","year":"2021","unstructured":"Schiattarella GG, et al. Xbp1s-FoxO1 axis governs lipid accumulation and contractile performance in Heart Failure with preserved ejection fraction. Nat Commun. 2021;12(1):1684.","journal-title":"Nat Commun"},{"issue":"1","key":"436_CR7","doi-asserted-by":"publisher","first-page":"23515","DOI":"10.1038\/s41598-021-02818-7","volume":"11","author":"T Yamada","year":"2021","unstructured":"Yamada T, et al. Hypertrophy of the ligamentum flavum in lumbar spinal canal stenosis is associated with abnormal accumulation of specific lipids. Sci Rep. 2021;11(1):23515.","journal-title":"Sci Rep"},{"issue":"8","key":"436_CR8","doi-asserted-by":"publisher","first-page":"9854","DOI":"10.1096\/fj.202000635R","volume":"34","author":"C Sun","year":"2020","unstructured":"Sun C, et al. Ligamentum Flavum fibrosis and hypertrophy: molecular pathways, cellular mechanisms, and future directions. Faseb j. 2020;34(8):9854\u201368.","journal-title":"Faseb j"},{"issue":"10","key":"436_CR9","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1080\/17425255.2016.1206888","volume":"12","author":"R van der Sluis","year":"2016","unstructured":"van der Sluis R, Erasmus E. Xenobiotic\/medium chain fatty acid: CoA ligase - a critical review on its role in fatty acid metabolism and the detoxification of benzoic acid and aspirin. Expert Opin Drug Metab Toxicol. 2016;12(10):1169\u201379.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"436_CR10","doi-asserted-by":"publisher","first-page":"571641","DOI":"10.3389\/fmolb.2020.571641","volume":"7","author":"C Ma","year":"2020","unstructured":"Ma C, et al. Identification of a Novel Tumor Microenvironment-Associated eight-gene signature for Prognosis Prediction in Lung Adenocarcinoma. Front Mol Biosci. 2020;7:571641.","journal-title":"Front Mol Biosci"},{"key":"436_CR11","doi-asserted-by":"publisher","first-page":"112639","DOI":"10.1016\/j.psychres.2019.112639","volume":"282","author":"X Qi","year":"2019","unstructured":"Qi X, et al. An integrative analysis of transcriptome-wide association study and mRNA expression profile identified candidate genes for attention-deficit\/hyperactivity disorder. Psychiatry Res. 2019;282:112639.","journal-title":"Psychiatry Res"},{"issue":"1","key":"436_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.21873\/invivo.11782","volume":"34","author":"A Koseler","year":"2020","unstructured":"Koseler A, et al. Genome-wide DNA methylation profiling of blood from monozygotic twins discordant for Myocardial Infarction. Vivo. 2020;34(1):361\u20137.","journal-title":"Vivo"},{"issue":"1","key":"436_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s13075-021-02625-5","volume":"23","author":"Y Cao","year":"2021","unstructured":"Cao Y, et al. Integrative analysis of genome-wide DNA methylation and single-nucleotide polymorphism identified ACSM5 as a suppressor of lumbar ligamentum flavum hypertrophy. Arthritis Res Ther. 2021;23(1):251.","journal-title":"Arthritis Res Ther"},{"issue":"W1","key":"436_CR14","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50(W1):W216\u2013w221.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"436_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/s12967-022-03677-0","volume":"20","author":"Y Duan","year":"2022","unstructured":"Duan Y, et al. TCF7\/SNAI2\/miR-4306 feedback loop promotes hypertrophy of ligamentum flavum. J Transl Med. 2022;20(1):468.","journal-title":"J Transl Med"},{"issue":"1","key":"436_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13062-023-00383-9","volume":"18","author":"Y Cao","year":"2023","unstructured":"Cao Y, et al. LncRNA XIST facilitates hypertrophy of ligamentum flavum by activating VEGFA-mediated autophagy through sponging miR-302b-3p. Biol Direct. 2023;18(1):25.","journal-title":"Biol Direct"},{"issue":"5","key":"436_CR17","doi-asserted-by":"publisher","first-page":"763","DOI":"10.5713\/ab.21.0371","volume":"35","author":"S Pan","year":"2022","unstructured":"Pan S, et al. Curcumin represses lipid accumulation through inhibiting ERK1\/2-PPAR-\u03b3 signaling pathway and triggering apoptosis in porcine subcutaneous preadipocytes. Anim Biosci. 2022;35(5):763\u201377.","journal-title":"Anim Biosci"},{"key":"436_CR18","doi-asserted-by":"publisher","first-page":"108391","DOI":"10.1016\/j.pharmthera.2023.108391","volume":"245","author":"H Chen","year":"2023","unstructured":"Chen H, et al. PPAR-\u03b3 signaling in nonalcoholic fatty Liver Disease: Pathogenesis and therapeutic targets. Pharmacol Ther. 2023;245:108391.","journal-title":"Pharmacol Ther"},{"key":"436_CR19","doi-asserted-by":"crossref","unstructured":"Wang Y et al. PPARs as metabolic regulators in the liver: lessons from Liver-Specific PPAR-Null mice. Int J Mol Sci. 2020; 21(6).","DOI":"10.3390\/ijms21062061"},{"key":"436_CR20","doi-asserted-by":"publisher","first-page":"101376","DOI":"10.1016\/j.redox.2019.101376","volume":"29","author":"M Lamas Bervejillo","year":"2020","unstructured":"Lamas Bervejillo M, et al. A FABP4-PPAR\u03b3 signaling axis regulates human monocyte responses to electrophilic fatty acid nitroalkenes. Redox Biol. 2020;29:101376.","journal-title":"Redox Biol"},{"key":"436_CR21","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ebiom.2019.02.015","volume":"41","author":"TNM Hua","year":"2019","unstructured":"Hua TNM, et al. Inhibition of oncogenic src induces FABP4-mediated lipolysis via PPAR\u03b3 activation exerting cancer growth suppression. EBioMedicine. 2019;41:134\u201345.","journal-title":"EBioMedicine"},{"issue":"2","key":"436_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.atherosclerosis.2015.03.042","volume":"240","author":"M Boss","year":"2015","unstructured":"Boss M, et al. FABP4 inhibition suppresses PPAR\u03b3 activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages. Atherosclerosis. 2015;240(2):424\u201330.","journal-title":"Atherosclerosis"},{"issue":"2","key":"436_CR23","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/biolre\/ioac059","volume":"107","author":"K Gopalakrishnan","year":"2022","unstructured":"Gopalakrishnan K, et al. Hyperandrogenism diminishes maternal-fetal fatty acid transport by increasing FABP4-mediated placental lipid accumulation\u2020. Biol Reprod. 2022;107(2):514\u201328.","journal-title":"Biol Reprod"},{"key":"436_CR24","doi-asserted-by":"crossref","unstructured":"Liu W et al. Genipin attenuates Diabetic Cognitive impairment by reducing lipid Accumulation and promoting mitochondrial Fusion via FABP4\/Mfn1 signaling in Microglia. Antioxid (Basel). 2022; 12(1).","DOI":"10.3390\/antiox12010074"},{"issue":"18","key":"436_CR25","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1016\/j.molcel.2021.08.027","volume":"81","author":"H Yoon","year":"2021","unstructured":"Yoon H, et al. Lipid metabolism in sickness and in health: emerging regulators of lipotoxicity. Mol Cell. 2021;81(18):3708\u201330.","journal-title":"Mol Cell"},{"key":"436_CR26","doi-asserted-by":"publisher","first-page":"1187989","DOI":"10.3389\/fcell.2023.1187989","volume":"11","author":"Y Wang","year":"2023","unstructured":"Wang Y, et al. Lipid metabolism and Tumor immunotherapy. Front Cell Dev Biol. 2023;11:1187989.","journal-title":"Front Cell Dev Biol"},{"key":"436_CR27","doi-asserted-by":"publisher","first-page":"1123567","DOI":"10.3389\/fonc.2023.1123567","volume":"13","author":"R Fang","year":"2023","unstructured":"Fang R, Yan L, Liao Z. Abnormal lipid metabolism in cancer-associated cachexia and potential therapy strategy. Front Oncol. 2023;13:1123567.","journal-title":"Front Oncol"},{"issue":"6","key":"436_CR28","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cmet.2012.04.006","volume":"15","author":"IJ Goldberg","year":"2012","unstructured":"Goldberg IJ, Trent CM, Schulze PC. Lipid metabolism and toxicity in the heart. Cell Metab. 2012;15(6):805\u201312.","journal-title":"Cell Metab"},{"key":"436_CR29","doi-asserted-by":"publisher","first-page":"981766","DOI":"10.3389\/fphar.2022.981766","volume":"13","author":"LJ Sun","year":"2022","unstructured":"Sun LJ, et al. Xin-Ji-Er-Kang protects heart from ischemia-reperfusion injury by rebalancing lipid metabolism. Front Pharmacol. 2022;13:981766.","journal-title":"Front Pharmacol"},{"key":"436_CR30","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ejmech.2019.01.067","volume":"166","author":"AZ Mirza","year":"2019","unstructured":"Mirza AZ, Althagafi II, Shamshad H. Role of PPAR receptor in different Diseases and their ligands: physiological importance and clinical implications. Eur J Med Chem. 2019;166:502\u201313.","journal-title":"Eur J Med Chem"},{"issue":"Pt 2","key":"436_CR31","doi-asserted-by":"publisher","first-page":"125008","DOI":"10.1016\/j.ijbiomac.2023.125008","volume":"242","author":"M Miao","year":"2023","unstructured":"Miao M, et al. Targeting PPARs for therapy of Atherosclerosis: a review. Int J Biol Macromol. 2023;242(Pt 2):125008.","journal-title":"Int J Biol Macromol"},{"key":"436_CR32","doi-asserted-by":"publisher","first-page":"115733","DOI":"10.1016\/j.taap.2021.115733","volume":"431","author":"JL Zhuang","year":"2021","unstructured":"Zhuang JL, et al. Amentoflavone prevents ox-LDL-induced lipid accumulation by suppressing the PPAR\u03b3\/CD36 signal pathway. Toxicol Appl Pharmacol. 2021;431:115733.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"7","key":"436_CR33","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1007\/s11427-020-1814-1","volume":"64","author":"P Yu","year":"2021","unstructured":"Yu P, et al. Upregulation of the PPAR signaling pathway and accumulation of lipids are related to the morphological and structural transformation of the dragon-eye goldfish eye. Sci China Life Sci. 2021;64(7):1031\u201349.","journal-title":"Sci China Life Sci"},{"key":"436_CR34","doi-asserted-by":"crossref","unstructured":"Lee JH et al. Heat-killed Enterococcus faecalis prevents adipogenesis and high Fat Diet-Induced obesity by inhibition of lipid Accumulation through inhibiting C\/EBP-\u03b1 and PPAR-\u03b3 in the insulin signaling pathway. Nutrients. 2022; 14(6).","DOI":"10.3390\/nu14061308"},{"issue":"3","key":"436_CR35","doi-asserted-by":"publisher","first-page":"216","DOI":"10.5551\/jat.48710","volume":"26","author":"M Furuhashi","year":"2019","unstructured":"Furuhashi M. Fatty acid-binding protein 4 in Cardiovascular and Metabolic Diseases. J Atheroscler Thromb. 2019;26(3):216\u201332.","journal-title":"J Atheroscler Thromb"},{"issue":"4","key":"436_CR36","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.cell.2020.07.027","volume":"182","author":"B Li","year":"2020","unstructured":"Li B, et al. SnapShot: FABP functions. Cell. 2020;182(4):1066\u20131066e1.","journal-title":"Cell"},{"key":"436_CR37","doi-asserted-by":"publisher","first-page":"566535","DOI":"10.3389\/fimmu.2020.566535","volume":"11","author":"Y Feng","year":"2020","unstructured":"Feng Y, et al. Inhibition of fatty acid-binding protein 4 attenuated kidney fibrosis by mediating macrophage-to-myofibroblast transition. Front Immunol. 2020;11:566535.","journal-title":"Front Immunol"},{"key":"436_CR38","doi-asserted-by":"publisher","first-page":"173570","DOI":"10.1016\/j.ejphar.2020.173570","volume":"887","author":"M Shi","year":"2020","unstructured":"Shi M, et al. Pharmacological inhibition of fatty acid-binding protein 4 alleviated kidney inflammation and fibrosis in hyperuricemic Nephropathy. Eur J Pharmacol. 2020;887:173570.","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"436_CR39","doi-asserted-by":"publisher","first-page":"E1083","DOI":"10.1210\/jc.2010-2084","volume":"96","author":"CM Scifres","year":"2011","unstructured":"Scifres CM, et al. Fatty acid binding protein 4 regulates intracellular lipid accumulation in human trophoblasts. J Clin Endocrinol Metab. 2011;96(7):E1083\u201391.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"436_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bbrc.2010.01.086","volume":"393","author":"J Song","year":"2010","unstructured":"Song J, et al. Metformin reduces lipid accumulation in macrophages by inhibiting FOXO1-mediated transcription of fatty acid-binding protein 4. Biochem Biophys Res Commun. 2010;393(1):89\u201394.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"436_CR41","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41419-021-03850-1","volume":"12","author":"Y Chen","year":"2021","unstructured":"Chen Y, et al. Pre-emptive pharmacological inhibition of fatty acid-binding protein 4 attenuates kidney fibrosis by reprogramming tubular lipid metabolism. Cell Death Dis. 2021;12(6):572.","journal-title":"Cell Death Dis"},{"issue":"4","key":"436_CR42","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.7150\/thno.66814","volume":"12","author":"QY Chen","year":"2022","unstructured":"Chen QY, et al. The peroxisome proliferator-activated receptor agonist rosiglitazone specifically represses tumour metastatic potential in chromatin inaccessibility-mediated FABP4-deficient gastric cancer. Theranostics. 2022;12(4):1904\u201320.","journal-title":"Theranostics"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-023-00436-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-023-00436-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-023-00436-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T22:05:16Z","timestamp":1699913116000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologydirect.biomedcentral.com\/articles\/10.1186\/s13062-023-00436-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,14]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["436"],"URL":"https:\/\/doi.org\/10.1186\/s13062-023-00436-z","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,14]]},"assertion":[{"value":"18 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from each patient, and ethical approval was obtained from the Institutional Research Ethics Committee of the Zhujiang Hospital of Southern Medical University (Approval No.: 2021-ky-122-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read the final manuscript and approved the manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}